First US drug priced at more than $1 million may be on the horizon – CNBC
Investor’s Business Daily |
First US drug priced at more than $1 million may be on the horizon
CNBC New gene therapies that aim to cure hemophilia, a disease affecting the blood's ability to clot, may carry prices of $1.5 million or more, analysts at Leerink wrote … Hemophilia Gene Therapies |
